(Q43614828)

25 November 2017

title

The combined effects of novel tocotrienols and lovastatin on lipid metabolism in chickens (English)

1 reference

25 November 2017

A A Qureshi

1

1 reference

25 November 2017

D M Peterson

series ordinal

2

1 reference

25 November 2017

language of work or name

1 reference

1 May 2001

1 reference

25 November 2017

1 reference

25 November 2017

volume

156

1 reference

25 November 2017

issue

1

1 reference

25 November 2017

page(s)

39-47

1 reference

gamma-Tocotrienol as a hypocholesterolemic and antioxidant agent in rats fed atherogenic diets

25 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900612-2

Regulation of the mevalonate pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900612-2

Effect of atherogenic diet on chicken plasma lipids and lipoproteins.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900612-2

Lipid Biosynthesis in the Chick. A Consideration of Site of Synthesis, Influence of Diet and Possible Regulatory Mechanisms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900612-2

Comparative aspects of lipogenesis in mammalian tissues

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900612-2

Effect of AMO 1618 on cholesterol and fatty acid metabolism in chickens and rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900612-2

Cholesterol and fatty acid synthesis in swine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900612-2

Response of hypercholesterolemic subjects to administration of tocotrienols

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900612-2

Dietary alpha-tocopherol attenuates the impact of gamma-tocotrienol on hepatic 3-hydroxy-3-methylglutaryl coenzyme A reductase activity in chickens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900612-2

A receptor-mediated pathway for cholesterol homeostasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900612-2

Lipid-lowering drugs. An overview of indications and optimum therapeutic use.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900612-2

Mevinolin and colestipol stimulate receptor-mediated clearance of low density lipoprotein from plasma in familial hypercholesterolemia heterozygotes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900612-2

Vitamin E plus aspirin compared with aspirin alone in patients with transient ischemic attacks

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900612-2

Dietary tocotrienols reduce concentrations of plasma cholesterol, apolipoprotein B, thromboxane B2, and platelet factor 4 in pigs with inherited hyperlipidemias.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900612-2

Lowering of serum cholesterol in hypercholesterolemic humans by tocotrienols (palmvitee)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900612-2

Effects of gamma-tocotrienol on ApoB synthesis, degradation, and secretion in HepG2 cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900612-2

Effect of garlic on carbohydrate metabolism and lipid synthesis in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900612-2

Regression of coronary artery disease as a result of intensive lipid-lowering therapy in men with high levels of apolipoprotein B

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900612-2

The Lipid Research Clinics Coronary Primary Prevention Trial results. I. Reduction in incidence of coronary heart disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900612-2

Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900612-2

Reduction of mortality in the Stockholm Ischaemic Heart Disease Secondary Prevention Study by combined treatment with clofibrate and nicotinic acid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900612-2

10.1016/S0021-9150(00)00612-2

7 January 2021

Identifiers

DOI

1 reference

25 November 2017

1 reference